Structure and function of the factor VIII gene and protein

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Factor VIII (FVIII) is a large protein encoded by a gene on the X chromosome.
• FVIII comprises multiple domains (A1-A2-B-A3-C1-C2) with homology to other proteins like ceruloplasmin.
• The B domain is variable and can be partially deleted without affecting FVIII's therapeutic efficacy in hemophilia A.

Purpose of the Study:

• To elucidate the structural and functional characteristics of Factor VIII.
• To understand the molecular mechanisms underlying FVIII activation and inactivation.
• To provide insights into the role of FVIII in hemostasis and thrombosis.

Main Methods:

• Analysis of FVIII gene structure and protein domains.
• Construction of molecular models based on known crystal structures.
• Investigation of FVIII secretion, stabilization by von Willebrand factor (vWF), and activation to FVIIIa.

Main Results:

• FVIII is secreted as a heterodimer and circulates bound to vWF with a half-life of approximately 10 hours.
• Activation to FVIIIa involves thrombin cleavage, transforming it into a heterotrimer essential for intrinsic FX activation.
• FVIIIa inactivation occurs via A2 domain dissociation or cleavage by activated protein C.

Conclusions:

• The structure and domain organization of FVIII are critical for its function in blood coagulation.
• Understanding FVIII activation and inactivation pathways is vital for hemostasis and thrombosis research.
• Recombinant FVIII variants with modified B domains show therapeutic potential for hemophilia A.